1
|
González Rodríguez II, Francisco AF, Moreira-Dill LS, Quintero A, Guimarães CLS, Fernandes CAH, Takeda AAS, Zanchi FB, Caldeira CAS, Pereira PS, Fontes MRM, Zuliani JP, Soares AM. Isolation and structural characterization of bioactive compound from Aristolochia sprucei aqueous extract with anti-myotoxic activity. Toxicon X 2020; 7:100049. [PMID: 32613196 PMCID: PMC7322210 DOI: 10.1016/j.toxcx.2020.100049] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 06/08/2020] [Accepted: 06/17/2020] [Indexed: 11/26/2022] Open
Abstract
A bioactive compound isolated from the stem extract of Aristolochia sprucei through High Performance Liquid Chromatography (HPLC) was identified via Nuclear Magnetic Resonance (NMR) as the aristolochic acid (AA). This compound showed an inhibitory effect over the myotoxic activity of Bothrops jararacussu and Bothrops asper venoms, being also effective against the indirect hemolytic activity of B. asper venom. Besides, AA also inhibited the myotoxic activity of BthTX-I and MTX-II with an efficiency greater than 60% against both myotoxins. Docking predictions revealed an interesting mechanism, through which the AA displays an interaction profile consistent with its inhibiting abilities, binding to both active and putative sites of svPLA2. Overall, the present findings indicate that AA may bind to critical regions of myotoxic Asp 49 and Lys49-PLA2s from snake venoms, highlighting the relevance of domains comprising the active and putative sites to inhibit these toxins.
Collapse
Affiliation(s)
- Isela I González Rodríguez
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, FCFRP, Universidade de São Paulo, USP, Ribeirão Preto, SP, Brazil
| | - Aleff F Francisco
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil.,Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Leandro S Moreira-Dill
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Aristides Quintero
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, FCFRP, Universidade de São Paulo, USP, Ribeirão Preto, SP, Brazil.,Centro de Informaciones e Investigaciones Toxicológicas y Químicas Aplicadas (CEIITOXQUIA) and Departamento de Química, FCNYE, Universidad Autónoma de Chiriquí, UNACHI, David, Panama
| | - César L S Guimarães
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Instituto Brasileiro Do Meio Ambiente e Dos Recursos Naturais Renováveis, IBAMA, Porto Velho, RO, Brazil
| | - Carlos A H Fernandes
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Agnes A S Takeda
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Fernando B Zanchi
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Instituto Nacional de Ciência e Tecnologia Em Epidemiologia da Amazônia Ocidental, INCT - EpiAmO, Brazil
| | - Cléopatra A S Caldeira
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Paulo S Pereira
- Unidade de Biotecnologia, Universidade de Ribeirão Preto, UNAERP, Ribeirão Preto, SP, Brazil.,Instituto Federal de Goiás, IFG, Goiania, GO, Brazil
| | - Marcos R M Fontes
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Juliana P Zuliani
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Laboratório de Imunologia Celular Aplicada a Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Centro Universitário São Lucas, UniSL, Porto Velho, RO, Brazil.,Instituto Nacional de Ciência e Tecnologia Em Epidemiologia da Amazônia Ocidental, INCT - EpiAmO, Brazil
| |
Collapse
|
2
|
Riffault-Valois L, Wattez C, Langrand J, Boucaud-Maitre D, Gaslonde T, Colas C, Nossin E, Blateau A, Michel S, Cachet X. Health risk associated with the oral consumption of "Chiniy-tref", a traditional medicinal preparation used in Martinique (French West Indies): Qualitative and quantitative analyses of aristolochic acids contained therein. Toxicon 2019; 172:53-60. [PMID: 31704310 DOI: 10.1016/j.toxicon.2019.10.241] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 10/10/2019] [Accepted: 10/30/2019] [Indexed: 12/15/2022]
Abstract
"Chiniy-tref" (CT) is a traditional preparation used in folk medicine in Martinique Island (French West Indies) that is nowadays mainly taken orally to prevent or act against any "manifestation of evil". CT is easily prepared at home by macerating larvae of the endemic swallowtail Battus polydamas (ssp.) cebriones (Dalman, 1823), sometimes accompanied by a leaf of its host-plant Aristolochia trilobata L., in commercial rum. We have previously reported the detection of nephrotoxic and carcinogenic aristolochic acids (AAs) I and II in CT, leading the Regional Health Agency (ARS) of Martinique to issue an alert regarding the potential risks associated with its consumption in 2015. In order to complete the toxicity risk assessment for oral consumption of CT, a full qualitative analysis of AAs and their analogues (AAAs) was performed, as well as a quantitative determination of the major AAs, namely AAs I and II. The phytochemical profiling of AAAs present in CT, that also corresponds to that of B. polydamas cebriones larvae feeding on A. trilobata, has been established for the first time by ultra-high performance liquid chromatography/electrospray ionization quadrupole time of-flight tandem mass spectrometry. AAs I and II were quantified in a small panel of tinctures by using a validated UHPLC/UV method, allowing us to estimate the probable daily intakes of these toxins by CT consumers. The results proved the existence of a real risk of renal toxicity and carcinogenicity associated with the chronic oral consumption of CT in Martinique, and more generally of similar "snake bottles" throughout the Caribbean.
Collapse
Affiliation(s)
- Ludivine Riffault-Valois
- UMR 8038 CiTCoM CNRS, Faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, F-75006, France
| | - Camille Wattez
- UMR 8038 CiTCoM CNRS, Faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, F-75006, France
| | - Jérôme Langrand
- Centre Antipoison de Paris, AP-HP Hôpital Lariboisière-Fernand Widal, Paris, F-75010, France
| | - Denis Boucaud-Maitre
- Dispositif de Toxicovigilance Antilles, Centre Hospitalier de la Basse-Terre, Basse-Terre, F-97100, France; Direction de la Recherche Clinique et de l'Innovation, Centre Hospitalo-Universitaire de Guadeloupe, Pointe-à-Pitre, F-97110, France
| | - Thomas Gaslonde
- UMR 8038 CiTCoM CNRS, Faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, F-75006, France
| | - Cyril Colas
- Institut de Chimie Organique et Analytique, ICOA UMR 7311 CNRS Université d'Orléans, Orléans, F-45071, France; Centre de Biophysique Moléculaire, CBM UPR 4301 CNRS, Orléans, F-45071, France
| | - Emmanuel Nossin
- Pharmacie Préchotaine, Le Prêcheur, F-97250, Martinique, France
| | - Alain Blateau
- Agence régionale de santé de Martinique, Fort de France, F-97200, Martinique, France
| | - Sylvie Michel
- UMR 8038 CiTCoM CNRS, Faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, F-75006, France
| | - Xavier Cachet
- UMR 8038 CiTCoM CNRS, Faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, F-75006, France.
| |
Collapse
|
3
|
Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2. J Mol Model 2019; 25:88. [PMID: 30847632 DOI: 10.1007/s00894-019-3954-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2018] [Accepted: 01/29/2019] [Indexed: 02/07/2023]
Abstract
Alternative treatments from plant-derived small molecules for neutralizing the venom lethality in snake envenomation are prevalent now. Elephantopus scaber, a tropical plant species has been recognized for its various pharmacological activities and especially anti-snake venom property; however, the molecular basis for this property is not understood. It is reported that snake venom PLA2 is a toxic factor with pharmacological effects independent of their catalytic activity. Here we report the inhibition of catalytic property of Cobra and Viper (group I and group II) snake venom PLA2 by the phytocompounds from E. scaber through molecular docking and dynamics studies. Initially, Lipinski's rule, ADMET, and molecular docking studies were carried out. Our results show that among 124 phytocompounds, crepiside E (deacylcynaropicrin-3' beta-glucopyranoside) has shown interactions with the conserved catalytic active site residues, His 48 and Asp 49, in both the PLA2s. Further, molecular dynamic simulations for 60 ns confirmed the stability of crepiside E in the active site of PLA2s and were found to be stable throughout the simulation. In order to understand the drug-likeness of crepiside E, pIC50 and MMGBSA scores were correlated by performing a linear regression analysis. Crepiside E was found to have similar chemical features to that of doxycycline, a known PLA2 inhibitor as indicated by a similarity score of 64.15%. Hence, it is concluded that crepiside E beta glucopyranoside present in Elephantopus scaber contributes to neutralizing the snake venom.
Collapse
|